Correlation of Cystatin-C and radionuclidic measurement method of glomerular filtration rate in patients with lung cancer receiving cisplatin treatment

Renal Failure

Volumn 36, Issue 7, 2014, Pages 1043-1050

  Oc, Murat Alper ^a   Demir, Hakan ^a   Cekmen, Mustafa Baki ^a   Isgoren, Serkan ^a   Gorur, Gozde Daglioz ^a   Bilgili, Umit ^a  

^a KOCAELI UNIVERSITY   (Turkey)

Author keywords

Cisplatin; Cystatin C; Glomerular filtration rate; Nephrotoxicity; Scintigraphy

Indexed keywords

CISPLATIN; CYSTATIN C; PENTETATE TECHNETIUM TC 99M; ANTINEOPLASTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LUNG CANCER; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TIME TO TREATMENT; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; DIAGNOSTIC USE; DRUG EFFECTS; KIDNEY; LUNG NEOPLASMS; MIDDLE AGED;

ANTINEOPLASTIC AGENTS; CISPLATIN; CYSTATIN C; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M PENTETATE;

EID: 84904695671     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2014.918813     Document Type: Article

References (36)

1. Brenner RM, Brenner BM. Disorders of the kidney and urinary tract. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill medical publishing division; 2009:1639-1722.
2. Kayaalp O. Tbbi farmakoloji. 9th ed. Ankara: Hacettepe-Taş; 2000.
3. Aydin F, Gungor F, Cengiz KA, et al. Comparison of glomerular filtration rate measurements with the two plasma sample and single plasma sample, gamma camera Gates, creatinine clearance, and prediction equation methods in potential kidney donors with normal renal function. Nucl Med Commun. 2008;29:157-165. (Pubitemid 350306774)
4. Grönroos MH, Jahnukainen T, Möttönen M, et al. Long-term follow-up of renal function after high-dose methotrexat treatment in children. Pediatr Blood Cancer. 2008;51:535-539.
5. Stabuc B, Vrhovec L, Stabuc-Silih M, et al. Improved prediction of decreased creatinine clearance by serum cystatin c: use in cancer patients before and during chemotherapy. Clin Chem. 2000;46: 193-197. (Pubitemid 30104242)
6. Holweger K, Bokemeyer C, Lipp HP. Accurate measurement of individual glomerular filtration rate in cancer patients: an ongoing challenge. J Cancer Res Clin Oncol. 2005;131: 559-567. (Pubitemid 41558547)
7. Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17:2937-2944. (Pubitemid 44484685)
8. Hubner RA, Goldstein R, Mitchell S, et al. Influence of co-morbidity on renal function assessment by Cockcroft-Gault calculation in lung cancer and mesothelioma patients receiving platinum-based chemotherapy. Lung Cancer. 2011;73:356-360.
9. Madero M, Mark J. Sarnak MJ, et al. Serum cystatin C as a marker of glomerular filtration rate. Curr Opin Nephrol Hypertens. 2006; 15:610-616.
10. Aydin F, Tezcan G, Gungor O, et al. Can serum cystatin C reflect the glomerular filtration rate accurately in pediatric patients under chemotherapeutic treatment? A comparative study with Tc-99m DTPA two-plasma sample method. Nucl Med Commun. 2010;31: 301-306.
11. Kumaresan R, Giri P. A comparison of serum cystatin c and creatinine with glomerular filtration rate in indian patients with chronic kidney disease. Oman Med J. 2011;6:421-425.
12. Sun X, Chen Y, Chen X, et al. Change of glomerular filtration rate in healthy adults with aging. Nephrology. 2009;14:506-513.
13. Hai-xia Li, Guo-bin Xu, Xue-jing W, et al. Diagnostic accuracy of various glomerular filtration rates estimating equations in patients with chronic kidney disease and diabetes. Chin Med J. 2010;123: 745-751.
14. Lipcsey M, Furebring M, Rubertsson S, et al. Significant differences when using creatinine, modification of diet in renal disease, or cystatin C for estimating glomerular filtration rate in ICU patients. Ups J Med Sci. 2011;116:39-46.
15. Thomas C, Thomas L. Renal failure-measuring the glomerular filtration rate. Dtsch Arztebl Int. 2009;106:849-854.
16. Benöhr P, Grenz A, Hartmann JT, et al. Cystatin C - a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res. 2006;29:32-35. (Pubitemid 43875170)
17. Lin HY, Lee SC, Lin SF, et al. Urinary neutrophil gelatinaseassociated lipocalin levels predict cisplatin-induced acute kidney injury better than albuminuria or urinary cystatin C levels. Kaohsiung J Med Sci. 2013;29:304-311.
18. Barnfield MC, Burniston MT, Reid U, et al. Cystatin C in assessment of glomerular filtration rate in children and young adults suffering from cancer. Nucl Med Commun. 2013;34:609-614.
19. Bölke E, Schieren G, Gripp S, et al. Cystatin C - a fast and reliable biomarker for glomerular filtration rate in head and neck cancer patients. Strahlenther Onkol. 2011;187:191-201.
20. Youssef A. Al-Tonbary, Ayman M, et al. Pretreatment cystatin c in children with malignancy: can it predict chemotherapy-induced glomerular filtration rate reduction during the induction phase? J Pediatr Hematol Oncol. 2004;26:336-341.
21. Nakai K, Kikuchi M, Fujimoto K, et al. Serum levels of cystatin C in patients with malignancy. Clin Exp Nephrol. 2008;12:132-139.
22. Chantler C, Barratt TM. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child. 1972;47:613-618.
23. Fleming JS. An improved equation for correcting slope-intercept measurements of glomerular filtration rate for the single exponential approximation. Nucl Med Commun. 2007;28:315-320. (Pubitemid 46673209)
24. Bröchner-Mortensen J. Routine methods and their reliability for assessment of glomerular filtration rate in adults, with special reference to total [51Cr]EDTA plasma clearance. Dan Med Bull. 1978;25:181-202. (Pubitemid 9036684)
25. Christensen AB, Groth S. Determination of 99mTc-DTPA clearance by a single plasma sample method. Clin Physiol. 1986;6: 579-588. (Pubitemid 17212115)
26. Watson WS. A simple method of estimating glomerular filtration rate. Eur J Nucl Med. 1992;19:827. doi: 10.1007/ BF00182829.
27. Hayran M, Hayran M. Saǧlk arastrmalar? için temel istatistik Ankara: Art Ofset Matbaaclk; 2011:312-324.
28. Yao X, Panichpisal K, Kurtzman N, et al. Cisplatin nephrotoxicity: a review. Am J Med Sci. 2007;334:115-124. (Pubitemid 47262919)
29. Grönroos MH, Jahnukainen T, Irjala K, et al. Comparison of glomerular function tests in children with cancer. Pediatr Nephrol. 2008;23:797-803.
30. Trimarchi H, Muryan A, Martino D, et al. Creatinine-vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease. J Nephrol. 2012;25:1003-1015.
31. Huang SH, Macnab JJ, et al. Performance of the creatinine-based and the cystatin C-basedglomerular filtration rate (GFR) estimating equations in a heterogenous sample of patients referred for nuclear GFR testing. Transl Res. 2011;157:357-367.
32. Morgan C, Senthilselvan A, Bamforth F, et al. Correlation between cystatin C- and renal scan-determined glomerular filtration rate in children with spina bifida. Pediatr Nephrol. 2008;23: 329-332.
33. Gerhardt T, Pöge U, Stoffel-Wagner B, et al. Estimation of glomerular filtration rates after orthotopic liver transplantation: evaluation of cystatin c-based equations. Liver Transpl. 2006;12: 1667-1672. (Pubitemid 44742547)
34. Bodnar L, Wcislo GB, Smoter M, et al. Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer. Kidney Blood Press Res. 2010;33:360-367.
35. Kos FT, Sendur MA, Aksoy S, et al. Evaluation of the renal function using cystatin C level in the patients receiving cisplatinbased chemotherapy. Ren Fail. 2013;35:705-710.
36. Sohrabian A, Noraddin FH, Flodin M, et al. Particle enhanced turbidimetric immunoassay for the determination of urine cystatin C on Cobas c501. Clin Biochem. 2012;44:339-344.